Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
15.40
-0.90 (-5.52%)
At close: Aug 28, 2026, 4:00 PM EDT
15.42
+0.02 (0.13%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Immunic Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 155.1 | 15.48 | 35.67 | 46.67 | 106.75 | 86.86 |
Short-Term Investments | - | - | - | - | 9.63 | - |
Cash & Short-Term Investments | 155.1 | 15.48 | 35.67 | 46.67 | 116.37 | 86.86 |
Cash Growth | 180.42% | -56.59% | -23.58% | -59.89% | 33.97% | -31.85% |
Other Receivables | 0.28 | 4.12 | 0.68 | 2.48 | 2.66 | 2.15 |
Receivables | 0.28 | 4.12 | 0.68 | 2.48 | 2.66 | 2.15 |
Prepaid Expenses | 2.45 | 2.06 | 1.87 | 2.31 | 5.61 | 15.98 |
Other Current Assets | - | 1.2 | 1.11 | 1.07 | 1.23 | - |
Total Current Assets | 157.83 | 22.87 | 39.33 | 52.53 | 125.86 | 104.99 |
Property, Plant & Equipment | 1.34 | 1.18 | 1.54 | 1.77 | 1.85 | 1.1 |
Goodwill | - | - | - | - | - | 32.97 |
Other Long-Term Assets | - | - | - | - | 0.04 | 0.04 |
Total Assets | 159.17 | 24.05 | 40.87 | 54.3 | 127.75 | 139.1 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.67 | 10.14 | 7.85 | 5.1 | 4.28 | 3.75 |
Accrued Expenses | 17.85 | 18.65 | 12.91 | 18.66 | 7.99 | 7.07 |
Current Portion of Leases | 0.24 | 0.47 | 0.74 | 0.7 | 0.57 | 0.41 |
Other Current Liabilities | 0.5 | 1.37 | 0.68 | 0.27 | 0.24 | 0.18 |
Total Current Liabilities | 31.26 | 30.62 | 22.18 | 24.73 | 13.08 | 11.4 |
Long-Term Leases | 0.33 | 0.11 | 0.26 | 0.64 | 0.99 | 0.58 |
Total Liabilities | 31.59 | 30.73 | 22.44 | 25.37 | 14.07 | 11.99 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 800.05 | 599.24 | 525.61 | 436.06 | 427.93 | 324.24 |
Retained Earnings | -675.26 | -608.57 | -511.4 | -410.89 | -317.28 | -196.87 |
Comprehensive Income & Other | 2.77 | 2.65 | 4.21 | 3.76 | 3.04 | -0.25 |
Total Common Equity | 127.58 | -6.67 | 18.43 | 28.93 | 113.68 | 127.12 |
Shareholders' Equity | 127.58 | -6.67 | 18.43 | 28.93 | 113.68 | 127.12 |
Total Liabilities & Equity | 159.17 | 24.05 | 40.87 | 54.3 | 127.75 | 139.1 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.57 | 0.58 | 1 | 1.33 | 1.56 | 0.99 |
Net Cash (Debt) | 154.53 | 14.91 | 34.66 | 45.34 | 114.81 | 85.87 |
Net Cash Growth | 184.42% | -57.00% | -23.55% | -60.51% | 33.70% | -32.10% |
Net Cash Per Share | 5.54 | 0.96 | 3.46 | 10.23 | 36.08 | 36.30 |
Filing Date Shares Outstanding | 13.64 | 13.05 | 9.02 | 8.99 | 4.44 | 2.79 |
Total Common Shares Outstanding | 13.64 | 12.04 | 9.02 | 4.52 | 3.93 | 2.63 |
Working Capital | 126.57 | -7.75 | 17.16 | 27.81 | 112.79 | 93.59 |
Book Value Per Share | 9.35 | -0.55 | 2.04 | 6.40 | 28.92 | 48.27 |
Tangible Book Value | 127.58 | -6.67 | 18.43 | 28.93 | 113.68 | 94.15 |
Tangible Book Value Per Share | 9.35 | -0.55 | 2.04 | 6.40 | 28.92 | 35.75 |